Does Factor XIII Deficiency Cause Permanent Joint Damage?
At a Glance
While classic hemophilia frequently causes spontaneous joint bleeds and permanent joint damage, Factor XIII deficiency rarely does. However, people with FXIII deficiency can still experience delayed joint bleeding after an injury. Regular factor replacement therapy helps prevent these bleeds.
In this answer
3 sections
Does Factor XIII deficiency cause permanent joint damage like hemophilia does? For most people, the answer is no. While classic hemophilia is well known for causing frequent bleeding into the joints, Factor XIII (FXIII) deficiency causes a very different pattern of bleeding [1][2]. Permanent joint damage is rarely a primary concern for people living with FXIII deficiency [3][4]. However, joint bleeds can occasionally occur, usually after an injury, and it is still important to prevent them to protect your long-term mobility [5].
Understanding the Differences in Bleeding Patterns
To understand why your joints are generally safer with FXIII deficiency, it helps to look at how this condition differs from classic hemophilia (Hemophilia A and B).
- Classic Hemophilia: The hallmark symptom of severe hemophilia is spontaneous hemarthrosis (bleeding into a joint space) [6]. When joint bleeds happen repeatedly over time, the blood irritates the joint lining and wears down the cartilage. This leads to arthropathy (chronic joint disease or permanent joint damage), which causes long-term pain and limits movement [7].
- Factor XIII Deficiency: People with FXIII deficiency tend to experience bleeding in different areas of the body [1]. The most common features of severe FXIII deficiency include bleeding from the umbilical cord at birth, delayed wound healing, soft tissue bleeds, and a higher risk of bleeding in the brain [8][2]. Spontaneous joint bleeds are relatively rare [7][9].
Because joint bleeding is not a central feature of FXIII deficiency, chronic joint destruction is not considered a primary complication of the condition [3][4].
Can Joint Bleeds Still Happen in FXIII Deficiency?
Yes. While you are unlikely to experience the frequent, spontaneous joint bleeds seen in hemophilia, intra-articular bleeding (bleeding inside a joint) and intramuscular bleeding (bleeding inside a muscle) are still possible [5].
In FXIII deficiency, these bleeds typically happen after a physical trauma or injury, rather than occurring out of nowhere [1]. Because the FXIII protein is responsible for stabilizing blood clots, a clot inside an injured joint or muscle might form normally at first but break down too quickly [10]. This means you might feel fine immediately after a bump or fall, but experience delayed bleeding a day or two later [5].
If a joint bleed does happen and is left untreated, the trapped blood can cause inflammation. Theoretically, repeated trauma and bleeding into the same joint over time could lead to long-term joint damage [6][5]. This is why protecting your joints and treating any suspected bleeds promptly remains essential.
Protecting Your Joints Long-Term
The best way to prevent joint damage—and more serious complications—is through regular treatment and vigilance after an injury.
- Prophylactic therapy: For severe congenital FXIII deficiency, the standard of care is regular, preventative intravenous (IV) infusions of factor replacement therapy [11][12]. This treatment provides the missing FXIII protein your body needs to stabilize clots before major bleeding events can start [13]. Because FXIII stays in the body for a relatively long time, these preventative infusions are usually spaced out over several weeks.
- Know the early warning signs: Because joint bleeds are uncommon in FXIII deficiency, you might not know what they feel like. Before a joint becomes visibly swollen or extremely painful, early signs of a bleed can include a bubbling or tingling sensation, warmth, tightness, or a slight loss of motion in the joint.
- Prompt treatment for injuries: If you experience a hard fall, a sprain, or a direct blow to a joint, you should seek medical attention, even if you feel fine initially. Because FXIII deficiency causes delayed bleeding, a joint might swell and become painful hours or days after the event [10].
- Consult your team before high-impact activities: Since trauma is the primary trigger for joint bleeds in FXIII deficiency, it is wise to talk to your hematologist or a physical therapist before starting contact sports or high-impact activities.
By maintaining a consistent prophylaxis schedule and managing injuries quickly, the risk of developing any permanent joint damage from FXIII deficiency is extremely low [12][14].
Common questions in this guide
Does Factor XIII deficiency cause permanent joint damage?
Why do joint bleeds happen days after an injury with FXIII deficiency?
What are the early warning signs of a joint bleed?
How are joint bleeds prevented in severe Factor XIII deficiency?
Should I go to the doctor for a minor joint injury if I feel fine?
Questions for Your Doctor
5 questions
- •What specific symptoms or early warning signs should prompt me to call you or go to the emergency room after a joint injury?
- •What is our protocol if I injure a joint on the weekend or after clinic hours, given that my bleeding might be delayed?
- •Should I consult with a physical therapist to help strengthen the muscles around my joints to prevent injuries?
- •Are there specific high-impact sports or activities I should avoid completely, and which are safe for me?
- •How do my current Factor XIII trough levels influence my risk of delayed bleeding after a minor bump or sprain?
Questions for You
3 questions
- •Have I ever experienced swelling, tingling, warmth, or tightness in a joint a day or two after a minor injury without realizing it could be a bleed?
- •How quickly do I usually seek medical advice after a fall or sprain, and do I need to change my habits to account for delayed bleeding risks?
- •Are there any recurring joint pains or stiffness I haven't mentioned to my hematology team?
References
References (14)
- 1
Congenital factor XIII deficiency caused by F13A1 gene mutations presenting with intracranial hemorrhage: a case report.
Wang H, Yang R, Li J
Frontiers in pediatrics 2025; (13()):1732065 doi:10.3389/fped.2025.1732065.
PMID: 41488895 - 2
Delayed and prolonged umbilical stump bleeding in a Caucasian newborn as a presenting feature of factor XIII deficiency.
Lim DBN, Mangles S, Goturu A
BMJ case reports 2022; (15(10)) doi:10.1136/bcr-2022-248743.
PMID: 36207057 - 3
Abnormally Prolonged Bleeding After an Arthroscopic Knee Reconstruction Because of an Inherited Factor XIII Deficiency: A Case Report.
Wattakavanich N, Boonrod A, Wanitpongpun C, Tharakulphan S
JBJS case connector 2021; (11(4)) doi:10.2106/JBJS.CC.21.00419.
PMID: 35102034 - 4
Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency.
Dorgalaleh A, Naderi M, Shamsizadeh M
Annals of hematology 2016; (95(3)):451-5 doi:10.1007/s00277-015-2568-8.
PMID: 26692088 - 5
Factor XIII deficiency and head trauma: management and therapy.
Ribizzi G, Farinini D, Gentile R, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2015; (36(10)):1933-4 doi:10.1007/s10072-015-2284-0.
PMID: 26116182 - 6
Factor XIII Deficiency: A Review of Biology, Testing, and Treatment.
Jacobs JW, Booth GS, Costa V, et al.
Clinical hematology international 2026; (8(1)):10-25 doi:10.46989/001c.155180.
PMID: 41583548 - 7
Recurrent Bleeding after Head Trauma Caused by Acquired Factor XIII Deficiency.
Wakabayashi N, Nishioka H, Yuzuriha S
Plastic and reconstructive surgery. Global open 2022; (10(2)):e4109 doi:10.1097/GOX.0000000000004109.
PMID: 35186643 - 8
Recurrent Intracerebral Hemorrhage in a 30-Year-Old Male With Factor XIII Deficiency: A Case Report.
Sadiq F, Nawaz S, Gohar A, et al.
Case reports in hematology 2025; (2025()):4790198 doi:10.1155/crh/4790198.
PMID: 41439206 - 9
Gynecological and obstetric outcome in the French cohort of women with factor XIII deficiency.
Rugeri L, Martinaud C, Beurrier P, et al.
Thrombosis research 2020; (191()):22-25 doi:10.1016/j.thromres.2020.04.010.
PMID: 32360976 - 10
A Case of Factor XIII Deficiency Identified by Recurrent Postoperative Bleeding After Tonsillectomy.
Teramura T, Sakai A, Hamada M, et al.
Clinical case reports 2026; (14(2)):e72006 doi:10.1002/ccr3.72006.
PMID: 41659946 - 11
Safety and effectiveness of recombinant factor XIII-A2 in congenital factor XIII deficiency: Real-world evidence.
Poulsen LH, Kerlin BA, Castaman G, et al.
Research and practice in thrombosis and haemostasis 2022; (6(2)):e12628 doi:10.1002/rth2.12628.
PMID: 35243202 - 12
Factor XIII Deficiency: A Review of Clinical Presentation and Management.
Pelcovits A, Schiffman F, Niroula R
Hematology/oncology clinics of North America 2021; (35(6)):1171-1180 doi:10.1016/j.hoc.2021.07.009.
PMID: 34607717 - 13
Factor XIII Deficiency: Laboratory, Molecular, and Clinical Aspects.
Dorgalaleh A, Jozdani S, Zadeh MK
Seminars in thrombosis and hemostasis 2025; (51(2)):155-169 doi:10.1055/s-0044-1796673.
PMID: 39613144 - 14
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.
Bouttefroy S, Meunier S, Milien V, et al.
British journal of haematology 2020; (188(2)):317-320 doi:10.1111/bjh.16133.
PMID: 31414482
This page explains joint bleeding risks in Factor XIII deficiency for educational purposes only. Always contact your hematologist or healthcare provider for medical advice, especially after an injury or if you suspect a bleed.
Get notified when new evidence is published on Factor XIII Deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.